68Ga-Citrate PET of Healthy Volunteers
NCT01951300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2015-11-04
Summary
This study investigates whole-body distribution kinetics of intravenously administered Gallium-69 (68Ga) citrate by positron emission tomography (PET)/computed tomography (CT). Thereafter, radiation dosimetry of 68Ga-citrate PET/CT will be determined.
Conditions
- Healthy
Interventions
- OTHER
-
Gallium-68 citrate
Single intravenous bolus injection of 200 MBq of Gallium-68 citrate radiopharmaceutical
Sponsors & Collaborators
-
Turku University Hospital
lead OTHER_GOV
Principal Investigators
-
Anne Roivainen · Turku University Hospital
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- Finland
Study Locations
More Related Trials
-
Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.
NCT05285696 ·Status: COMPLETED ·Phase: PHASE1
-
68Ga-labeled NY105 PET Imaging in Patients
NCT05691881 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)
NCT04139395 ·Status: WITHDRAWN ·Phase: PHASE3
-
Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT
NCT03519659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
NCT05212103 ·Status: ENROLLING_BY_INVITATION
-
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
NCT02327442 ·Status: UNKNOWN
-
68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies
NCT05515783 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
NCT02311556 ·Status: COMPLETED ·Phase: PHASE1
-
Tracer Targeting FAP PET Imaging in Patients
NCT05691894 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT
NCT01000181 ·Status: SUSPENDED
-
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
NCT02496013 ·Status: UNKNOWN ·Phase: PHASE1
-
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
NCT05543317 ·Status: COMPLETED ·Phase: NA
-
Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients
NCT00961831 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
NCT05160480 ·Status: ENROLLING_BY_INVITATION
-
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
NCT06684028 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients
NCT04480619 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers
NCT06398730 ·Status: COMPLETED ·Phase: PHASE1
-
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor
NCT06844110 ·Status: RECRUITING ·Phase: NA
-
Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors
NCT07023640 ·Status: RECRUITING ·Phase: NA
-
Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy
NCT04903340 ·Status: COMPLETED
-
Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer
NCT04481230 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma
NCT05111314 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Siderophores for Imaging Infection Using 68Ga-DFO
NCT05285072 ·Status: UNKNOWN
-
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer
NCT04831541 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Development Study of Check-Cap Imaging System in Healthy Volunteers
NCT03989180 ·Status: COMPLETED